We are monitoring the impact of COVID-19 on North America Glucose Monitoring Device Market Get in touch with us for detailed analysis Know More
Share on

North America Glucose Monitoring Device Market Research Report – Segmented By Device Type, Application & Country (the United States, Canada and Rest of North America) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2022 to 2027)

Published: January, 2022
ID: 568
Pages: 142

North America Glucose Monitoring Device Market Size (2022 to 2027)

The glucose monitoring device market in North America is a very fast-growing market and expected to reach USD 0.91 billion by 2027 from USD 0.70 billion in 2022, at a CAGR of 5.54% during the forecast period. North America rules the glucose monitoring device market with the highest market value and 34% in the global market in 2022. It is the dominating market in the recent development, with the USA nearly accounting for more than one-third of the worldwide market share.

Continuous glucose monitoring results help patients regulate their food intake, exercise, and medications. The device contains sensors for checking the glucose levels from the interstitial fluid. The sensor has a period where it can be used in one place and then replaced. This device monitors the glucose levels over time, allowing the patients to identify low and high sugar levels, which are more dangerous. Whereas for the self-monitoring devices, people have to test, and it monitors the level at that particular time and not before that.

The growing incidence of diabetes in North American countries is majorly accelerating market growth. The rising older people population, a large number of steps taken by the government for controlling diabetes and treatment, and the presence of key players in this region further fuelled the market's growth rate.

High costs associated with the glucose monitoring devices are expected to showcase a negative impact on the market. People living in rural areas are not well unaware of the devices, insufficient reimbursement policies and lack of a uniform format for showcasing results are the significant challenges to the market.

This research report on the North America Glucose Monitoring Devices Market has been segmented and sub-segmented into the following categories:

  • By Device Type: Continuous Wearable Devices and Self-Monitoring Devices
  • By Application: Hospitals, Clinics & Diagnostic Centres, Home Setting, and Ambulatory Settings
  • By Country: The United States, Canada, and Rest of North America

Regionally, North America dominated the global market in 2019.

The U.S. is leading the North America glucose monitoring devices market during the assessment period. Growing healthcare expenditure, huge patient population, and complete approval of technology advancements favor market growth. Around 2.9 billion funds for the diabetes industry like Glooko have developed new creative designs from startup companies. The growing number of product launches and FDA approvals for the launch of products and improving patient comfort are to surge the market growth.

The Canadian market is next to the United States in showing promising growth in the North American market. The country is expected to deliver cost-effective solutions for diabetes is likely to dominate the market over the next decade. Increasing demand for these CGM devices, rising obesity rates, unenergetic lifestyles, and computer literate population are the major causes of this region's growth. Extensive usage of these devices bolsters the market growth in this region.

Companies playing a dominant role in the North America Glucose Monitoring Device Market profiled in this report are Roche Diagnostics, LifeScan, Bayer Health care, Abbott Diabetes care Inc., AgaMatrix Inc., Arkray Inc., Medtronic, DexCom Inc., Nova Biomedical Corporation, and Terumo Europe NV.

1. Introduction                 

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods          

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction               

                2.2 Research Phases      

                                2.2.1 Secondary Research

                                2.2.2 Primary Research

                                2.2.3 Econometric Modelling

                                2.2.4 Expert Validation

                2.3 Analysis Design         

                2.4 Study Timeline          

3. Overview                       

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 New Developments               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                    

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market              

5. Market Segmentation                              

                5.1 By Device Type         

                                5.1.1 Continuous Wearable Devices

                               

                               

                                5.1.2 Self-Monitoring Devices

                                5.2 By Application           

                                5.2.1 Hospitals

                                5.2.2 Clinics and Diagnostic Centers

                                5.2.3 Home Setting

                                5.2.4 Ambulatory Settings

6. Geographical Analysis                              

                                6.1 Introduction

                                6.2 United States

                                6.3 Canada 

7. Strategic Analysis                       

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8. Market Leaders' Analysis                        

                8.1 Roche Diagnostics    

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Strategic Evaluation and Operations

                                8.1.4 Financial analysis

                                8.1.5 Legal issues

                                8.1.6 Recent Developments

                                8.1.7 SWOT analysis

                                8.1.8 Analyst View

                8.2 LifeScan       

                8.3 Bayer Health care    

                8.4 Abbott Diabetes care Inc      

                8.5 AgaMatrix Inc            

                8.6 Arkray Inc    

                8.7 Medtronic   

                8.8 DexCom Inc

                8.9 Nova Biomedical Corporation             

                8.10 Teruma Europe NV               

9. Competitive Landscape                           

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis       

                9.3 Agreements, collaborations and Joint Ventures         

                9.4 New Product Launches         

10. Expert Opinions                        

                10.1 Market Outlook     

                10.2 Investment Opportunities 

Appendix                           

                a) List of Tables

                b) List of Figures

  1. North America Glucose Monitoring Devices Market, By Region, From 2022 - 2027 (USD Billion)
  2. North America Glucose Monitoring Devices Market, By Device Type, From 2022 - 2027 (USD Billion)
  3. North America Continuous Wearable Devices Market, By Region, From 2022 - 2027 (USD Billion)
  4. North America Continuous Wearable Devices Market, By Device Type, From 2022 - 2027 (USD Billion)
  5. North America Sensors Market, By Region, From 2022 - 2027 (USD Billion)
  6. North America Transmitters and Activators Market, By Region, From 2022 - 2027 (USD Billion)
  7. North America Self-Monitoring Devices Market, By Region, From 2022 - 2027 (USD Billion)
  8. North America Self-Monitoring Devices Market, By Device Type, From 2022 - 2027 (USD Billion)
  9. North America Blood Glucose Meters Market, By Region, From 2022 - 2027 (USD Billion)
  10. North America Blood Glucose Strips Market, By Region, From 2022 - 2027 (USD Billion)
  11. North America Lancets Market, By Region, From 2022 - 2027 (USD Billion)
  12. North America Haemoglobin A1C testing Kits Market, By Region, From 2022 - 2027 (USD Billion)
  13. North America Glucose Monitoring Devices Market, By Application, From 2022 - 2027 (USD Billion)
  14. North America Hospitals Market, By Region, From 2022 - 2027 (USD Billion)
  15. North America Clinics and Diagnostic Centers Market, By Region, From 2022 - 2027 (USD Billion)
  16. North America Home Setting Market, By Region, From 2022 - 2027 (USD Billion)
  17. North America Ambulatory Settings Market, By Region, From 2022 - 2027 (USD Billion)
  18. United States Glucose Monitoring Devices Market, By Device Type, From 2022 - 2027 (USD Billion)
  19. United States Continuous Wearable Devices Market, By Device Type, From 2022 - 2027 (USD Billion)
  20. United States Self-Monitoring Devices Market, By Device Type, From 2022 - 2027 (USD Billion)
  21. United States Glucose Monitoring Devices Market, By Application, From 2022 - 2027 (USD Billion)
  22. Canada Glucose Monitoring Devices Market, By Device Type, From 2022 - 2027 (USD Billion)
  23. Canada Continuous Wearable Devices Market, By Device Type, From 2022 - 2027 (USD Billion)
  24. Canada Self-Monitoring Devices Market, By Device Type, From 2022 - 2027 (USD Billion)
  25. Canada Glucose Monitoring Devices Market, By Application, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample